---
category: news
title: "Galmed to employ OnKai's disruptive Artificial Intelligence (AI) in its Planned Phase 2a Clinical Trial in PSC"
excerpt: "OnKai's AI models redefine the methodologies and economics of clinical trials. TEL AVIV, Israel, July 10, 2023 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) (\"Galmed\""
publishedDateTime: 2023-07-10T13:44:00Z
originalUrl: "https://www.tmcnet.com/usubmit/-galmed-employ-onkais-disruptive-artificial-intelligence-ai-its-/2023/07/10/9844997.htm"
webUrl: "https://www.tmcnet.com/usubmit/-galmed-employ-onkais-disruptive-artificial-intelligence-ai-its-/2023/07/10/9844997.htm"
type: article
quality: 14
heat: 14
published: false

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI in Healthcare
  - AI

secured: "UaEP62D2yzTOHPR8rxdzUofjHdUHe7x19/GvZf10wX2HabVeuBFydZDSh1u6Mmpst+n8JNAy8HkafTtzwJMwQFkzV3HzEXZtANI6qFS991fBUyZO485nJxGpZUQCKsN0y98TOvFpLaWkQsmOyBeYPghQm6x1J/9O3l2pg5eBY2ptTGclGo6XnXnqLMCiiB2fqILX6eL9daSIFZ+u0RUSwu58VKMcdG0UH3vRv4KrWAt5Y4W7by73fF9e42Vb+wCeiVbEND9eOw3FLzCRG+CENX7f9Xl0mD1oy0QfV+andc7DubCxIoXhGve3I4nuuBk7MH+NQ+H4TdYJkTLpUqMGeO/iJ6u+hH8xZSW94QcM4r8=;/cDqfQRdkgA2EKtCJWYLfg=="
---

